Bidart J M, Bellet D
Rev Prat. 1989 Nov 11;39(26):2317-20.
Among the various antigens described as biological markers of ovarian cancer, only one, CA 125, is of value in clinical practice. CA 125 is not specific to epithelial ovarian cancer, but it is associated with this tumour. CA 125 assays are useless in the early detection of tumours in asymptomatic patients, but they are helpful to monitor the clinical course of treated cystadenocarcinoma of the ovary since a rise in CA 125 level may be observed several months before clinical or radiological evidence of ovarian malignancy is obtained. Finally, CA 125 determination is important before second-look laparotomy.
在被描述为卵巢癌生物学标志物的各种抗原中,只有一种,即CA 125,在临床实践中有价值。CA 125并非上皮性卵巢癌所特有,但它与这种肿瘤相关。CA 125检测对于无症状患者肿瘤的早期检测毫无用处,但有助于监测经治疗的卵巢囊腺癌的临床病程,因为在获得卵巢恶性肿瘤的临床或影像学证据前几个月,就可能观察到CA 125水平升高。最后,在二次剖腹探查术前测定CA 125很重要。